Multibagger stock sets record date for dividend, promoter holding up 8.68% QoQ
A mid-cap company with a market worth of Rs. 8,626.24 crore, Poly Medicure Ltd. operates in the hospital industry04-09-2022
04-09-2022
POLY MEDICURE LTD. - 531768 - Intimation Of Record Date For The Purpose Of Final Dividend For The FY 2021-22
Pursuant to the Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that the Record Date has been fixed as Monday, 19th September, 2022 for the purpose of ascertaining the entitlement of Members to the Final Dividend of ?2.50/- per equity share on the face value of ?5/- each on the equity shares of the Company for the FY 2021-22. If the final dividend as recommended by the board of directors is approved at the ensuing Annual General Meeting, payment of such dividend subject to deduction of tax at source, will be made within 30 days from the date of approval by the shareholders in the ensuing Annual General Meeting.03-09-2022
POLY MEDICURE LTD. - 531768 - Book Closure Of The Company From Tuesday, The 20Th September, 2022 To Monday, The 26Th September, 2022 (Both Days Inclusive) For Annual General Meeting.
Pursuant to the provisions of Regulation 42 of SEBI (LODR) Regulations, 2015, please be informed that: The Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 20th September, 2022 to Monday, the 26th September, 2022 (Both days inclusive) for Annual General Meeting. The Company will provide its members the facility to exercise their vote at the aforesaid AGM by electronic means on all resolutions set forth in the notice. The e-voting will commence on Friday, 23rd September, 2022 (9.00 A.M) and will end on Sunday, 25th September, 2022 (5.00 P.M). The voting rights of Members shall be as per the number of equity shares held by the members as on the cut-off date, which is 19th September, 2022.03-09-2022
POLY MEDICURE LTD. - 531768 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 30 and Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), please find enclosed herewith Annual Report of the Company for the financial year 2021-22.03-09-2022
POLY MEDICURE LTD. - 531768 - Notice Of 27Th Annual General Meeting, Annual Report For The Year 2021-22, Book Closure And E-Voting.
The 27th Annual General Meeting (AGM) of the Company will be held on Monday, 26th September, 2022, at 10.00 a.m. through Video Conferencing ('VC' or Other Audio Visual Means ('OAVM') in accordance with the MCA/SEBI circulars. Pursuant to Regulation 30 and Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), please find enclosed herewith Annual Report including Notice of AGM of the Company for the financial year 2021-22. In compliance with relevant circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India, the Notice convening the AGM and the Annual Report of the Company for the financial year 2021-22 are being sent to all the members of the Company whose email addresses are registered with the Company or Depository Participant(s).03-09-2022
POLY MEDICURE LTD. - 531768 - Clarification On Significant Movement In Share Price.
With reference to your e-mail ref.: L/SURV /ONL/PV /KS/2022-2023/2609, dated 2nd September, 2022, seeking clarification in respect of significant movement in price of the Company''s security across exchanges, in the recent past. In this regard we wish to inform you that, there is no information and/ or announcement (including impending announcement) which in our opinion may have a bearing on the Price/Volume behavior of the Company''s Scrip as traded across exchanges and which is required to be informed to stock exchanges in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Therefore, whatever the movement in price of the Company''s security is purely due to market conditions and absolutely market driven. Further kindly note that, the Company has been regularly disseminating unpublished price sensitive information as and when required in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.03-09-2022
POLY MEDICURE LTD. - 531768 - Clarification sought from Poly Medicure Ltd
The Exchange has sought clarification from Poly Medicure Ltd on September 2, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.03-09-2022
POLY MEDICURE LTD. - 531768 - Financial Results(Standalone & Consolidated) For The Quarter Ended 30Th June 2022 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022.04-08-2022
POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022. b) Allotted 18,050 Equity Shares of Rs. 5 each, pursuant to exercise of an option under Employee Stock Option Scheme, 2016. c) Ratification of Remuneration to M/ s. Jai Prakash & Company, Cost Accountants appointed as Cost Auditors of the Company for the Financial Year 2022-23, subject to the approval of the shareholders in the forthcoming Annual General Meeting. d) Resolution for Shareholders approval for re-appointment and remuneration of Mr. Vishal Baid as Sr. President (Sales and Marketing), of the Company, in the forthcoming Annual General Meeting.04-08-2022
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, 5th August, 2022 at 3.00 p.m. (IST) for discussing the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2022. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record. Thanking You,02-08-2022